Is Salarius Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Salarius Pharmaceuticals Inc (SLRX) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Salarius Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Salarius Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Salarius Pharmaceuticals Inc?

Muslim investors may consider investing in Salarius Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Salarius Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Salarius Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Salarius Pharmaceuticals Inc updated?

The Shariah compliance status of Salarius Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Salarius Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Salarius Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Salarius Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SLRX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: November 27, 2025

Report Source: 2025 3rd Quarter Report

Salarius Pharmaceuticals Inc. Stock Analysis SLRX

United States Health Care Nano Cap Report: Q3, 2025

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2015-01-29. The firm is focused on advancing its pipeline of peptide conjugate therapeutics engineered through its IMP3ACT platform that reduces the complexity of drug development and manufacturing. The company is focused on developing effective treatments for patients with cancer with high, unmet medical needs. The company’s lead candidate, seclidemstat (SP-2577), is being studied as treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options. Its pipeline consists of SP-3164 a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. SP-3164 is a next-generation cereblon-binding MG. SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold.

Key Statistics of Salarius Pharmaceuticals Inc (SLRX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.69$0.90

Today's Open

$0.71

Volume

P/E Ratio (TTM)

52 Week Range

$0.51$108.00

Market Cap

3.75M

Avg. Volume

101.70K

Dividend Yield

Financial Metrics & Statements of Salarius Pharmaceuticals Inc (SLRX)

FAQ's for Salarius Pharmaceuticals Inc (SLRX)

According to Musaffa’s Shariah screening methodology, Salarius Pharmaceuticals Inc (SLRX) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.